Massively Insightful

Selin Kurnaz
  • 0.0 (0)
  • Technology
  • Updated Monthly

Massively Insightful is a podcast hosted by Selin Kurnaz, Co-Founder and CEO of Massive Bio, an AI-driven precision oncology company connecting cancer patients to clinical trials across 17+ countries. Each episode brings together leading voices in oncology, healthcare innovation, and health technology to explore how artificial intelligence is transforming cancer care. From clinical trial access to precision medicine and digital health, we go deep on the ideas and breakthroughs shaping the future of oncology.

Episodes

  1. Aug 11

    Massively Insightful Ep. 2 – Bridging Pharma and Tech with AI | Chris Boone

    Chris Boone, Group Vice President of Research and Services for Life Sciences at Oracle, joins host Selin Kurnaz to trace his career journey from academic medicine and health IT to leading data and analytics at Pfizer, and now to bridging technology and healthcare at Oracle. Chris shares his personal mission of building "a world free of disease" and unpacks where generative AI will have the greatest impact in drug development, especially in discovery and target identification. The conversation covers the evolving role of real-world evidence (RWE) researchers in the age of AI agents, why AI governance is a strategic necessity rather than a compliance checkbox, and how digital twins could shift medicine from reactive to predictive care. Chris also reflects on his work with the Patient-Centered Outcomes Research Institute (PCORI) and leaves listeners with a call to stay bold in an era of unprecedented opportunity.

    Massively Insightful Ep. 2 – Bridging Pharma and Tech with AI | Chris Boone

  2. Jun 29

    Massively Insightful Ep. 1 – The Policy Behind Democratizing Clinical Trials | Abe Sutton

    In the inaugural episode of Massively Insightful, host Selin Kurnaz, Co-Founder and CEO of Massive Bio, sits down with Abe Sutton, a leading voice at the CMS Innovation Center, to explore the policy landscape shaping access to clinical trials. They discuss what it truly means to democratize cancer care, the role of government and payer policy in expanding trial eligibility, and how AI-driven platforms are closing the gap between patients and life-saving research. Whether you are a healthcare professional, a patient advocate, or simply curious about the future of oncology, this episode offers a rare look at the intersection of policy, technology, and human impact in cancer care.

    Massively Insightful Ep. 1 – The Policy Behind Democratizing Clinical Trials | Abe Sutton
  • 2 Episodes

About

Massively Insightful is a podcast hosted by Selin Kurnaz, Co-Founder and CEO of Massive Bio, an AI-driven precision oncology company connecting cancer patients to clinical trials across 17+ countries. Each episode brings together leading voices in oncology, healthcare innovation, and health technology to explore how artificial intelligence is transforming cancer care. From clinical trial access to precision medicine and digital health, we go deep on the ideas and breakthroughs shaping the future of oncology.

Information

  • Creator
    Selin Kurnaz
  • Years Active
    2026
  • Episodes
    2
  • Rating
    Clean
  • Copyright
    © Selin Kurnaz
  • Show Website
    Massively Insightful